0067-2000 NDC - EXCEDRIN ()

Drug Information

Product NDC: 0067-2000

Proprietary Name: Excedrin

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:9/27/2006

Package Information

No. Package Code Package Description Billing Unit
10067-2000-022 TABLET, FILM COATED in 1 POUCH (0067-2000-02)
20067-2000-101 BOTTLE in 1 CARTON (0067-2000-10) / 10 TABLET, FILM COATED in 1 BOTTLEEA
30067-2000-201 BOTTLE in 1 CARTON (0067-2000-20) / 200 TABLET, FILM COATED in 1 BOTTLEEA
40067-2000-241 BOTTLE in 1 CARTON (0067-2000-24) / 24 TABLET, FILM COATED in 1 BOTTLEEA
50067-2000-301 BOTTLE in 1 CARTON (0067-2000-30) / 30 TABLET, FILM COATED in 1 BOTTLE
60067-2000-331 BOTTLE in 1 CARTON (0067-2000-33) / 300 TABLET, FILM COATED in 1 BOTTLEEA
70067-2000-501 BOTTLE in 1 CARTON (0067-2000-50) / 50 TABLET, FILM COATED in 1 BOTTLEEA
80067-2000-771 BOTTLE in 1 CARTON (0067-2000-77) / 250 TABLET, FILM COATED in 1 BOTTLEEA
90067-2000-831 BOTTLE in 1 CARTON (0067-2000-83) / 125 TABLET, FILM COATED in 1 BOTTLE
100067-2000-911 BOTTLE in 1 CARTON (0067-2000-91) / 100 TABLET, FILM COATED in 1 BOTTLEEA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0067-2000The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEExcedrinThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXExtra Strength Pain RelieverA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE9/27/2006This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEGlaxoSmithKline Consumer Healthcare Holdings (US) LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023